CUGNO, MASSIMO
CUGNO, MASSIMO
Dipartimento di Fisiopatologia Medico-Chirurgica e dei Trapianti
Predictors of early treatment response to antihistamines and omalizumab in chronic spontaneous urticaria
2026 P. Calzari, E.M. Favale, M. Cugno, R. Asero, A.V. Marzano, S.M. Ferrucci
Severe chronic spontaneous urticaria responding and not responding to omalizumab: analysis of the prognostic value of known and novel in vitro variables
2026 R. Asero, P. Calzari, S. Ferrucci, M. Lorini, V. Carbonelli, S. Stella, D. Consonni, M. Cugno
The KLF4-CD46 axis: a novel therapeutic target in transplant-associated thrombotic microangiopathy and beyond
2026 M. Cugno, B. Lämmle
D-Dimer Elevation in Spontaneous Urticaria and Bullous Pemphigoid, Two Chronic Inflammatory Skin Diseases
2026 M. Cugno, R. Asero, A. Tedeschi
Hemophilia and hereditary angioedema: parallel therapeutic advances in genetic diseases of serine protease pathways
2026 M. Cugno, P.M. Mannucci
Efficacy of complement inhibition with pegcetacoplan in children with C3 glomerulopathy
2025 M.C. Mancuso, M. Cugno, S. Griffini, E. Grovetti, T. Nittoli, A. Mastrangelo, F. Tedesco, G. Montini, G. Ardissino
Thrombotic thrombocytopenic purpura (congenital and acquired) and haemolytic-uraemic syndrome
2025 P.M. Mannucci, M. Cugno, F. Peyvandi
Pathogenesis of Chronic Spontaneous Urticaria With or Without Angioedema
2025 S.S. Saini, R. Asero, M. Cugno, H. Park, E.T. Oliver
Measurement of cleaved high-molecular-weight kininogen in patients with hereditary angioedema due to C1-inhibitor deficiency: preanalytical and analytical optimization
2025 C. Suffritti, R. Gualtierotti, A. Zanichelli, M. Vidali, M. Cugno
Pathogenesis of chronic spontaneous urticaria beyond autoantibodies
2025 A. Tedeschi, R. Asero, S. Ferrucci, M. Cugno
Involvement of the contact pathway in COVID-19 coagulopathy
2025 M. Capecchi, C. Novembrino, M. Abbattista, M. Boscolo-Anzoletti, E. Galbiati, S. Griffini, E. Grovetti, L. Valenti, F. Blasi, G. Grasselli, R. Gualtierotti, M. Cugno, F. Peyvandi
Marginal zone lymphoma with anti-factor H IgM and atypical hemolytic uremic syndrome successfully treated with odronextamab
2025 G. Ardissino, P. Angelillo, M.C. Mancuso, S. Griffini, E. Grovetti, L. Porcaro, T. Ria, S. Marktel, F. Peyvandi, S. Luminari, A.J.M. Ferreri, M. Merli, M. Cugno
IgM autoantibodies to complement factor H in C3 glomerulopathy
2024 M. Cugno, M.C. Mancuso, F. Depetri, F. Peyvandi, G. Ardissino
Contact system activation and bradykinin generation in patients with idiopathic angioedema
2024 C. Suffritti, P. Calzari, F. Depetri, S. Griffini, E. Grovetti, R. Santacroce, M. Margaglione, M. Cugno
Outcome of atypical hemolytic uremic syndrome: role of triggers and complement abnormalities in the response to C5 inhibition
2024 G. Ardissino, D. Cresseri, M.C. Mancuso, V. Capone, L. Porcaro, V. Amico, M. Tangredi, E. Grovetti, S. Griffini, G. Castellano, G. Montini, D. Consonni, M. Cugno, M. Domenico, Z. Marco, V. Luca, V. Giuseppe, V. Enrico, V. Marta, V. Simona, V. Paolo, V. Pellu, T. Martina, T. Silvia, T. Laura, T. Francesco, T. Chiara, T. Lorella, T. Aristide, T. Sara, T. Monica, T. Elisabetta, S. Tiziana, S. Chiara, S. Giuseppe, S. Fabian, S. Chiara, S. Paola, S. Laura, R. Rodolfo, R. Roberto, R. Evangeline, R. Angelo, R. Barbara, R. Angelo, R. Andrea, R. Teresa, P. Leonardo, P. Ilaria, P. Vera, P. Gianmarco, P. Lucia, P. Giulia, P. Giorgio, P. Jacopo, P. Werner, P. Andrea, P. Antonello, P. Giuseppe, P. Fabio, O. Francesco, N. Maria, N. Alessandro, M. Lorenza, N. Valentina, M. Nicola, M. Enrico, M. Tommaso, M. Cristina, M. Sabrina, M. Concetta, M. Alessandra, M. Florjan, M. Marco, M. Laura, M. Verna, M. Sarah, M. Jacopo, M. Silvio, M. Rita, M. Carmelita, M. Annunziata, L. Selena, L. Scola, I. Alessandro, I. Francesco, G. Gina, G. Mario, G. Fabio, G. Giovanni, G. Andrea, F. Lucrezia, F. Riccardo, F. Maria, F. Domenico, F. Angelo, F. Roberta, F. Luca, D. Vecchio, D. Nunzia, D. Philippis, D. Biase, D. Delia, D. Marco, C. Olga, C. Raffaella, C. Luigia, C. Ciro, C. Giacomo, C. Calogero, C. Doriana, C. Francesco, C. Alessandro, C. Nicola, C. Donatella, C. Aldo, C. Alessandra, C. Leonardo, C. Valeria, B. Alessandro, B. Maurizio, B. Brigida, B. Alessandra, B. Maria, B. Bruno, A. Alice, A. Karen, A. Carlo, A. Alessandro, A. Barbara
Therapies for Chronic Spontaneous Urticaria: Present and Future Developments
2024 R. Asero, P. Calzari, S. Vaienti, M. Cugno
Omalizumab for the Treatment of Chronic Spontaneous Urticaria in Adults and Adolescents: An Eight-Year Real-Life Experience
2024 P. Calzari, A. Chiei Gallo, F. Barei, E. Bono, M. Cugno, A.V. Marzano, S.M. Ferrucci
Nailfold Videocapillaroscopic Alterations as Markers of Microangiopathy in COVID-19 Patients
2023 R. Gualtierotti, S.E. Fox, F. Da Silva Lameira, A. Giachi, L.V.C. Valenti, M.O. Borghi, P. Luigi Meroni, M. Cugno, F. Payvandi
IgG and IgE Autoantibodies to IgE Receptors in Chronic Spontaneous Urticaria and Their Role in the Response to Omalizumab
2023 C.A. Maronese, S.M. Ferrucci, C. Moltrasio, M. Lorini, V. Carbonelli, R. Asero, A.V. Marzano, M. Cugno
Thyroid Autoimmunity in CSU: A Potential Marker of Omalizumab Response?
2023 R. Asero, S.M. Ferrucci, P. Calzari, D. Consonni, M. Cugno